US Bancorp’s Dextera Surgical Inc. DXTR Stock Holding History

US Bancorp’s Portfolio DXTR Stock Details DXTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-400	Closed	-$1K	–	3699
2016 Q2	$1K	Buy	+400	New	+$819	﹤0.01%	3520

Other funds holding DXTR

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

US Bancorp's DXTR Position: Q3 2016 in Review

US Bancorp sold out of Dextera Surgical Inc. (DXTR) in Q3 2016, closing a stake of 400 shares — an estimated $1K sold.

US Bancorp first reported a position in DXTR in Q2 2016 and held it in 1 quarter. The position peaked at $1K in Q2 2016. 23 funds tracked by Wall St. Rank hold DXTR as of Q3 2016.

US Bancorp reported no remaining Dextera Surgical Inc. position as of Q3 2016 after selling out during the quarter.
US Bancorp sold 400 Dextera Surgical Inc. shares in Q3 2016, an estimated $1K.
US Bancorp first reported a position in Dextera Surgical Inc. in Q2 2016 and held it in 1 quarter.
US Bancorp's Dextera Surgical Inc. position peaked at $1K in Q2 2016.
23 funds tracked by Wall St. Rank held Dextera Surgical Inc. as of Q3 2016.

Based on US Bancorp's 13F filing for Q3 2016, filed 4 Nov 2016.